117 related articles for article (PubMed ID: 31483831)
1. Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
PLOS ONE Editors
PLoS One; 2019; 14(9):e0222257. PubMed ID: 31483831
[No Abstract] [Full Text] [Related]
2. Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
PLOS ONE Editors
PLoS One; 2019; 14(9):e0222507. PubMed ID: 31504076
[No Abstract] [Full Text] [Related]
3. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma.
Wei Q; Xu X; Wang C; Zhuang R; Zhuang L; Zhou L; Xie H; Wu J; Zhang M; Shen Y; Wang W; Zheng S
Gut Liver; 2016 Jul; 10(4):604-10. PubMed ID: 27074818
[TBL] [Abstract][Full Text] [Related]
5. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
Ferreiro AO; Vazquez-Millán MA; López FS; Gutiérrez MG; Diaz SP; Patiño MJ
Transplant Proc; 2014 Dec; 46(10):3496-501. PubMed ID: 25498079
[TBL] [Abstract][Full Text] [Related]
6. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
Rajab A; Pelletier RP; Henry ML; Ferguson RM
Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
[TBL] [Abstract][Full Text] [Related]
7. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.
Rajab A; Pelletier RP; Ferguson RM; Elkhammas EA; Bumgardner GL; Henry ML
Transplantation; 2007 Nov; 84(9):1131-7. PubMed ID: 17998868
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
Klintmalm GB; Davis GL; Teperman L; Netto GJ; Washburn K; Rudich SM; Pomfret EA; Vargas HE; Brown R; Eckhoff D; Pruett TL; Roberts J; Mulligan DC; Charlton MR; Heffron TG; Ham JM; Douglas DD; Sher L; Baliga PK; Kinkhabwala M; Koneru B; Abecassis M; Millis M; Jennings LW; Fasola CG
Liver Transpl; 2011 Dec; 17(12):1394-403. PubMed ID: 21850690
[TBL] [Abstract][Full Text] [Related]
10. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.
Cillo U; Bechstein WO; Berlakovich G; Dutkowski P; Lehner F; Nadalin S; Saliba F; Schlitt HJ; Pratschke J
Transplant Rev (Orlando); 2018 Jul; 32(3):142-150. PubMed ID: 29709248
[TBL] [Abstract][Full Text] [Related]
11. Improved cardiovascular risk factors in pediatric renal transplant recipients on steroid avoidance immunosuppression: A study of the Midwest Pediatric Nephrology Consortium.
Weaver DJ; Selewski D; Janjua H; Iorember F
Pediatr Transplant; 2016 Feb; 20(1):59-67. PubMed ID: 26585354
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.
Toso C; Merani S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2010 Apr; 51(4):1237-43. PubMed ID: 20187107
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation.
Tarantino A; Montagnino G; Ponticelli C
Drug Saf; 1995 Sep; 13(3):145-56. PubMed ID: 7495501
[TBL] [Abstract][Full Text] [Related]
15. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy.
Felkel TO; Smith AL; Reichenspurner HC; LaFleur B; Lutz JF; Kanter KR; Gravanis MB; Johnston TS
J Heart Lung Transplant; 2002 May; 21(5):530-9. PubMed ID: 11983542
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.
Colhoun ED; Forsberg CG; Chavin KD; Baliga PK; Taber DJ
Surgery; 2017 Mar; 161(3):830-836. PubMed ID: 27771158
[TBL] [Abstract][Full Text] [Related]
17. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
18. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
Saab S; McTigue M; Finn RS; Busuttil RW
Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.
Moray G; Kirnap M; Akdur A; Soy E; Tezcaner T; Boyvat F; Ozdemir H; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():30-2. PubMed ID: 26640906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
